Match Context and Document information |
These search terms are highlighted: dea verification
URL: | https://www.deadiversion.usdoj.gov/faq/registration-faq.html |
Depth: | 2 clicks away from Home |
Size: | 51,570 bytes |
Modified: | 2024-05-29 08:47:24 |
Categories: | -None- |
Title: | Diversion Control Division | Registration Q&A |
Description: | -None- |
Keywords: | Diversion Control Division |
Meta data: | -None- |
Body: | DEA.Registration.Help@dea.gov
1.800.882.9539
Search
Home
About Us
Program Description
Customer Service Plan
DEA Forms & Applications
Mailing Addresses
Meeting & Events
Privacy Notice
What's New
Registration
Registration
CMEA Required Training & Self-Certification
Quota Applications
Marihuana Growers Information
Schedule I Controlled Substances Research Information
Notice of Registration
Reporting
ARCOS
BCM Online
Chemical Import/Export
Declarations
CSOS
Theft/Loss Reporting
Import/Export
Medical Missions
Quotas
Registrant Record of
Controlled Substances Destroyed
Regulated Machines
(Tableting and Encapsulating)
Reports Required by 21 CFR
SORS
Submit a Tip to DEA
Year-end Reports
Resources
Administrative Actions
Chemical Control Program
CMEA (Combat Meth
Epidemic Act)
Controlled Substances Schedules
DEA Regulatory Priorities
DEA TOX
Drug Disposal Information
Drug & Chemical Information
EPCS (Electronic Prescriptions for
Controlled Substances)
Federal Register Notices
Guidance Document Portal
Medications for Opioid Use Disorder
National Prescription Drug
Take Back Day
NFLIS
OPIOID (PHE) Information
Publications & Manuals
Questions & Answers
Telemedicine
Title 21 Code of Federal Regulations
Title 21 USC Codified CSA
Contact Us
Registration Q&A
Home
Resources
Questions & Answers
Registration Q&A
Chemical Handlers
For Q&As regarding Chemical Handlers Registration
Registration
Question: Does DEA require that a practitioner take special classes, or
some type of continuing education, before they can apply for, or reapply
for, a DEA registration?
Answer: Individual states may have educational requirements in order to
obtain and maintain a valid license in that state. DEA requires that all
state licensing requirements be met in order to obtain a DEA registration
in that state. 21 U.S.C. 823(g)(1) and (4).
In addition, all practitioners, who are not solely veterinarians, when
applying for a new registration or renewing their registration, must
satisfy either the training, credentialing or educational requirements
identified in section 1263 of the CAA 2023. [1] Please see the Q&A that DEA
posted on its website in reference to the training, credentialing, or
educational requirements, and related attestation. Practitioners can find
additional information on SAMHSA's website at Recommendations for
Curricular Elements in Substance Use Disorders Training | SAMHSA.
EO-DEA182R1, DEA-DC-076, September 21, 2023
[1] Pub. L. No. 117-328, div. FF, tit. I(B), ch. 6, § 1263(a), 136 Stat.
4459 (2022).
Question: In light of the elimination of the DATA-Waiver (X-waiver)
requirement, do I need to take any action to get an updated DEA
registration certificate?
Answer: No action is needed on the part of registrants, as a result of the
statutory repeal of 21 U.S.C. 823(h)(2). On December 29, 2022, with the
signing of the CAA[i], Congress eliminated the DATA-Waiver requirement.
Specifically, Pub. L. No. 117-328, div. FF, tit. I(B), ch. 6, §
1262(a)(1), 136 Stat. 4459, 5681 (2022) removed the federal requirement for
practitioners to apply for a special waiver prior to prescribing
buprenorphine for the treatment of Opioid Use Disorder (OUD). It also
removed the requirement for the assignment of an identification number
(i.e., X-waiver number) associated with being a DATA-waived provider, for
inclusion with the registration issued to the practitioner. 21 U.S.C.
823(h)(2)(D)(ii). EO-DEA260, DEA-DC-067, March 22, 2023
Question: Can an individual practitioner, to include a mid-level
practitioner, use their home address as the principal place of business or
professional practice?
Answer: Yes. An individual practitioner is a physician, dentist,
veterinarian, or other individual licensed, registered, or otherwise
permitted, by the United States or the jurisdiction in which he/she
practices, to dispense a controlled substance in the course of professional
practice, but does not include a pharmacist, a pharmacy, or an
institutional practitioner. A mid-level practitioner means an individual
practitioner, other than a physician, dentist, veterinarian, or podiatrist,
who is licensed, registered, or otherwise permitted by the United States or
the jurisdiction in which he/she practices, to dispense a controlled
substance in the course of professional practice. Examples of mid-level
practitioners include, but are not limited to, health care providers such
as nurse practitioners, nurse midwives, nurse anesthetists, clinical nurse
specialists and physician assistants who are authorized to dispense
controlled substances by the State in which they practice. See 21 CFR
1300.01(b). In addition, individual and mid-level practitioners must also
be in compliance with applicable State, local or tribal laws.
DEA regulations require a separate registration for each principal place of
business or professional practice at one general physical location where
controlled substances are manufactured, distributed, imported, exported, or
dispensed by a person. 21 CFR 1301.12(a). DEA regulations do not prohibit
individual and mid-level practitioners from using their home address.
If an individual practitioner or mid-level practitioner does choose to use
their home address as a principal place of business or professional
practice, the location becomes a "controlled premises" and is subject to
unannounced inspections and administrative warrants under existing DEA
regulations. See 21 CFR 1316.01-1316.13. An individual practitioner or
mid-level practitioner whose DEA-registered location is a home must comply
with the established recordkeeping requirements (see 21 CFR 1304 and 1305)
and security requirements. See 21 CFR 1301.71, 1301.75 - 1301.76.
The contents of this document do not have the force and effect of law and
are not meant to bind the public in any way. This document is intended only
to provide clarity to the public regarding existing requirements under the
law, regulations, or Department of Justice policies. EO-DEA183, DEA-DC-052,
November 3, 2021 (Revised #1), Original Posted July 8, 2021
Question: Can I use a Post Office (PO) Box or Private Mailbox (PMB) address
as my registered address?
Answer: Your registered address must be the physical location of your
principal place of business or professional practice where controlled
substances are manufactured, distributed, imported, exported, or dispensed.
21 CFR 1301.12(a). In limited circumstances, a PO Box may be included in
addition to the physical business address, but a PO Box alone is not a
registered address. You may, however, use a different address for your
mailing address for DEA correspondence, which may be a PO Box or a PMB
address. EO-DEA206, DEA-DC-050, December 12, 2020
Question: Can I change the address on my current DEA registration or do I
have to get a new DEA registration for the new location?
Answer: Yes, you can change the address on your current DEA Registration.
If you prefer, you can also call your Local Diversion Field Office for
assistance, or you can ask a Registration Specialist for assistance by
calling 1-800-882-9539 or by emailing your request to
DEARegistrationHelp@dea.gov. EO-DEA185, November 2, 2020
Question: I live on the border between two states and I have a practice in
each state. Do I need to hold a separate DEA registration number in each
state?
Answer: Yes. Since DEA's authority to register practitioners to dispense
(including to prescribe) controlled substances is contingent, in part, upon
the applicant's authorization in the state in which he or she practices,
his or her controlled substance privileges and limits are determined by
that specific state. The Controlled Substances Act requires a separate
registration at each principal place of business or professional practice
where the controlled substances are distributed or dispensed. See 21 U.S.C.
822(e)(1), 21 CFR 1301.12(a). Therefore, a practitioner who maintains a
professional practice location in multiple states has established, for
registration purposes, a principal place of business in each of those
states. Consequently, DEA requires that the practitioner obtain a separate
DEA registration in each state. Further, to do so the practitioner must
first obtain authorization to handle controlled substances in each state
where he or she has an office. For additional information please see the
Final Rule titled: Clarification of Registration Requirements for
Individual Practitioners, which DEA published in the Federal Register on
December 1, 2006. EO-DEA181, November 2, 2020
Question: Once I obtain a DEA registration can I prescribe controlled
substances anywhere in the United States as it is a Federal number?
Answer: No. A DEA individual practitioner registration is based on a State
license to practice medicine and prescribe controlled substances. DEA
relies on State licensing boards to determine whether a practitioner is
qualified to dispense, prescribe, or administer controlled substances and
to determine which schedules he/she may dispense, prescribe, or administer.
State authority to conduct the above-referenced activities only confers
rights and privileges within the issuing State. Thus, a DEA registration
based on a State license cannot authorize controlled substance dispensing
outside the State. See Registration Requirements for Individual
Practitioners Operating in a "Locum Tenens" Capacity, 75 FR 55499, 55501
(Oct. 28, 2009); 21 U.S.C. 823(f); 21 CFR 1306.03(a). EO-DEA089, October
21, 2020
Question: Is a separate registration required for each principal place of
business or professional practice?
Answer: Yes. 21 CFR 1301.12(a), "A separate location is required for each
principal place of business or professional practice at one general
physical location where controlled substances are manufactured,
distributed, imported, exported, or dispensed by a person." EO-DEA090,
October 9, 2020
Question: I currently have a DEA registration to import controlled
substances into the United States. Do I need to obtain a separate DEA
registration as a chemical importer to also import a scheduled listed
chemical product (SLCP) as defined under the Combat Methamphetamine
Epidemic Act of 2005 (CMEA) (i.e., pseudoephedrine, ephedrine, or
phenylpropanolamine), or a drug product that contains a List I chemical?
Answer: No. Under specific circumstances a separate DEA registration as a
chemical importer is not required if you hold a registration to import
controlled substances. DEA regulations provide a waiver to the separate
registration requirement for certain List I chemical activities if the
person is already registered with DEA to import controlled substances. 21
CFR 1309.24. Specifically, any person who imports or exports an SLCP or
other product containing a List I chemical described and included in the
definition of a regulated transaction found at 21 CFR 1300.02(1)(iv) is not
required to obtain a separate registration for those activities if already
registered to import controlled substances. See 21 CFR 1309.24(c).
EO-DEA225, October 5, 2020
Question: I am a practitioner, but I never plan on administering,
dispensing, or prescribing a controlled substance. Must I have a DEA
registration?
Answer: No. DEA regulations require that "only persons actually engaged in"
the "dispens[ing] . . . of any controlled substance" hold a registration.
21 CFR 1301.11(a); see 21 U.S.C. 802(10) (defining "dispense" to include
"the prescribing and administering of a controlled substance"). EO-DEA191,
June 23, 2020
Disclaimer: Guidance documents, like this document, are not binding and
lack the force and effect of law, unless expressly authorized by statute or
expressly incorporated into a contract, grant, or cooperative agreement.
Consistent with Executive Order 13891 and the Office of Management and
Budget implementing memoranda, the Department will not cite, use, or rely
on any guidance document that is not accessible through the Department's
guidance portal, or similar guidance portals for other Executive Branch
departments and agencies, except to establish historical facts. To the
extent any guidance document sets out voluntary standards (e.g.,
recommended practices), compliance with those standards is voluntary, and
noncompliance will not result in enforcement action. Guidance documents may
be rescinded or modified in the Department's complete discretion,
consistent with applicable laws.
REGISTRATION
REPORTING
RESOURCES
CONTACT US
PRIVACY NOTICE
GET EMAIL UPDATES
Get Email Updates
×
Official U.S. Department of Justice Seal
The United States Department of Justice
You are now leaving a Department of Justice Web site.
You are about to access:
Email Updates
The Department of Justice does not endorse the organizations or views
represented by this site and takes no responsibility for, and exercises no
control over, the accuracy, accessibility, copyright or trademark
compliance or legality of the material contained on this site.
Thank you for visiting our site.
DEA.GOV
JUSTICE.GOV
USA.GOV
REGULATIONS.GOV
DOJ Privacy Policy
Section 508 Accessibility
DOJ Legal Policies & Disclaimers
FOIA
DIVERSION CONTROL DIVISION
U.S. Department of Justice
Drug Enforcement Administration
DIVERSION CONTROL DIVISION
8701 Morrissette Drive
Springfield, VA 22152
1.800.882.9539
|
|